scholarly journals 904P ACCURACY: A phase II trial of AL101, a selective gamma secretase inhibitor, in subjects with recurrent/metastatic (R/M) adenoid cystic carcinoma (ACC) harboring Notch activating mutations (Notchmut): Results of 6-mg cohort

2021 ◽  
Vol 32 ◽  
pp. S803-S804
Author(s):  
A.L. Ho ◽  
D.W. Bowles ◽  
C. Even ◽  
D. Hao ◽  
H. Kang ◽  
...  
Keyword(s):  
Adenoid Cystic Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Gamma Secretase ◽  
Activating Mutations ◽  
Adenoid Cystic ◽  
Secretase Inhibitor ◽  
Gamma Secretase Inhibitor

scholarly journals Response of NOTCH1-Activated Tracheal Adenoid Cystic Carcinoma to the Gamma Secretase Inhibitor Nirogacestat

2021 ◽  
pp. 1579-1583
Author(s):  
Rosalind Kieran ◽  
Bruno H. R. de Paula ◽  
Michael Hubank ◽  
Allanah Barker ◽  
Anna L. Paterson ◽  
...  
Keyword(s):  
Adenoid Cystic Carcinoma ◽  
Gamma Secretase ◽  
Adenoid Cystic ◽  
Secretase Inhibitor ◽  
Gamma Secretase Inhibitor

Alliance A091104: A phase II trial of MK-2206 in patients (pts) with progressive, recurrent/metastatic adenoid cystic carcinoma.

2015 ◽  
Vol 33 (15_suppl) ◽  
pp. 6039-6039 ◽  
Author(s):  
Alan Loh Ho ◽  
Nathan R. Foster ◽  
Jeffrey P. Meyers ◽  
Shyamprasad Deraje Vasudeva ◽  
Nora Katabi ◽  
...  
Keyword(s):  
Adenoid Cystic Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Adenoid Cystic

scholarly journals Phase II trial of dasatinib for recurrent or metastatic c-KIT expressing adenoid cystic carcinoma and for nonadenoid cystic malignant salivary tumors

2016 ◽  
Vol 27 (2) ◽  
pp. 318-323 ◽  
Author(s):  
S.J. Wong ◽  
T. Karrison ◽  
D.N. Hayes ◽  
M.S. Kies ◽  
K.J. Cullen ◽  
...  
Keyword(s):  
Adenoid Cystic Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Adenoid Cystic

Abstract CT165: A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma

2021 ◽  
Author(s):  
Glenn J. Hanna ◽  
Anne O'Neill ◽  
Jennifer M. Cutler ◽  
Michelle Flynn ◽  
Tushara Vijaykumar ◽  
...  
Keyword(s):  
Retinoic Acid ◽  
Adenoid Cystic Carcinoma ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Adenoid Cystic ◽  
Trans Retinoic Acid ◽  
All Trans Retinoic Acid

P1-343: A phase II study of the gamma-secretase inhibitor avagacestat (BMS-708163) in predementia Alzheimer's disease

2013 ◽  
Vol 9 ◽  
pp. P283-P283 ◽  
Author(s):  
Vlad Coric ◽  
Stephen Salloway ◽  
Christopher van Dyck ◽  
Wendy Kerselaers ◽  
Stephen Kaplita ◽  
...  
Keyword(s):  
Alzheimer’S Disease ◽  
Alzheimer's Disease ◽  
Phase Ii ◽  
Phase Ii Study ◽  
Gamma Secretase ◽  
Secretase Inhibitor ◽  
Gamma Secretase Inhibitor
Sign in / Sign up

Export Citation Format

Share Document